Table 2.
Predictor | OR (95% CI) | P values |
Demographics | ||
Age | 1.033 (0.997 to 1.071) | 0.075 |
Gender | ||
Female | Ref | Ref |
Male | 0.750 (0.317 to 1.777) | 0.513 |
Deafness-related factors | ||
Duration of deafness-operated ear | 1.004 (0.982 to 1.027) | 0.738 |
Preoperative CVC score | 0.986 (0.971 to 1.003) | 0.101 |
Tinnitus-related factors | ||
Tinnitus duration | 0.964 (0.912 to 1.019) | 0.193 |
Tinnitus severity | ||
Mild | Ref | Ref |
Moderate | 0.776 (0.118 to 5.112) | 0.787 |
Severe | 0.690 (0.086 to 5.573) | 0.720 |
Localisation tinnitus | ||
Unilateral | Ref | Ref |
Bilateral | 0.358 (0.139 to 0.919) | 0.033 |
Surgery-related factors | ||
Follow-up duration | 1.100 (0.944 to 1.283) | 0.223 |
Localisation cochlear implant versus tinnitus | ||
Cochlear implant contralateral to tinnitus side | Ref | Ref |
Cochlear implant ipsilateral to tinnitus side | 0.381 (0.077 to 1.896) | 0.239 |
Unilateral cochlear implant, bilateral tinnitus | 0.217 (0.059 to 0.790) | 0.021 |
Surgical approach | ||
Cochleostomy | Ref | Ref |
Round window | 0.921 (0.329 to 2.576) | 0.876 |
Insertion | ||
Partial | Ref | Ref |
Full | 4.435 (0.510 to 8.567) | 0.177 |
Brand cochlear implant | ||
Cochlear | Ref | Ref |
MedEl | 1.421 (0.568 to 3.558) | 0.453 |
Advanced Bionics | 2.404 (0.550 to 0.515) | 0.244 |
Difference hearing threshold at 125 Hz | 1.005 (0.993 to 1.017) | 0.444 |
Difference hearing threshold at 250 Hz | 1.015 (0.999 to 1.031) | 0.071 |
Difference hearing threshold at 500 Hz | 1.006 (0.987 to 1.026) | 0.533 |
Difference hearing threshold at 1000 Hz | 1.012 (0.986 to 1.038) | 0.374 |
OR >1: in favour of tinnitus recovery.
P values <0.157 (Akaike’s criterion) are presented in bold.
CVC, Consonant-Vowel-Consonant test; Ref, reference.